Half-year report · Q2

Period2024-01-01 → 2024-06-30
Filed2024-08-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥264m2024-01-01 → 2024-06-30StandaloneNet sales
Revenue¥682m2023-01-01 → 2023-12-31StandaloneNet sales (5-year summary)
Revenue¥359m2023-01-01 → 2023-06-30StandaloneNet sales
Operating income−¥581m2024-01-01 → 2024-06-30StandaloneOperating income
Operating income−¥659m2023-01-01 → 2023-06-30StandaloneOperating income
Ordinary income−¥563m2024-01-01 → 2024-06-30StandaloneOrdinary income
Ordinary income−¥1.2bn2023-01-01 → 2023-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥662m2023-01-01 → 2023-06-30StandaloneOrdinary income
Profit before tax−¥562m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Profit before tax−¥661m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Net income−¥564m2024-01-01 → 2024-06-30StandaloneProfit loss
Net income−¥1.2bn2023-01-01 → 2023-12-31StandaloneNet income loss (5-year summary)
Net income−¥664m2023-01-01 → 2023-06-30StandaloneProfit loss
Total assets¥1.6bnat 2024-06-30StandaloneAssets
Total assets¥1.8bnat 2023-12-31StandaloneAssets
Total assets¥1.7bnat 2023-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥487mat 2024-06-30StandaloneLiabilities
Total liabilities¥594mat 2023-12-31StandaloneLiabilities
Net assets / equity¥1.1bnat 2024-06-30StandaloneNet assets
Net assets / equity¥1.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.1bnat 2023-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2024-06-30StandaloneCash and deposits
Cash and deposits¥1.3bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.7bnat 2022-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥677m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥595m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥173,0002023-01-01 → 2023-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥82,0002023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥455m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥667m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥113m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-10.212024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.622023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-13.72023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio68.0%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio65.1%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio67.2%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued56,387,000at 2024-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued52,640,200at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued48,503,800at 2023-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥269m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2024-01-01 → 2024-06-30−¥447m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2024-01-01 → 2024-06-30¥135m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30−¥312m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥266m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2023-01-01 → 2023-06-30−¥602m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2023-01-01 → 2023-06-30¥359m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2023-01-01 → 2023-06-30¥359m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2023-01-01 → 2023-06-30¥209m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥359m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥359m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30−¥393m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有 限 責 任 監 査 法 人 ト ー マ ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)鈴  木  基  之
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)三  浦  靖  晃
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior1YTDDuration_NonConsolidatedMember358889000JPY
Net sales (5-year summary)CurrentYTDDuration_NonConsolidatedMember263728000JPY
Net sales (5-year summary)Prior1YearDuration_NonConsolidatedMember682464000JPY
Ordinary income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember-662139000JPY
Ordinary income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember-563345000JPY
Ordinary income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember-1217240000JPY
Net income loss (5-year summary)Prior1YTDDuration_NonConsolidatedMember-663655000JPY
Net income loss (5-year summary)CurrentYTDDuration_NonConsolidatedMember-563958000JPY
Net income loss (5-year summary)Prior1YearDuration_NonConsolidatedMember-1220018000JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YTDDuration_NonConsolidatedMember-JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)CurrentYTDDuration_NonConsolidatedMember-JPY
Equity in earnings losses of affiliates if equity method is applied (5-year summary)Prior1YearDuration_NonConsolidatedMember-JPY
Capital stock (5-year summary)Prior1QuarterInstant_NonConsolidatedMember2106252000JPY
Capital stock (5-year summary)CurrentQuarterInstant_NonConsolidatedMember341497000JPY
Capital stock (5-year summary)Prior1YearInstant_NonConsolidatedMember2388422000JPY
Total number of issued shares (5-year summary)Prior1QuarterInstant_NonConsolidatedMember48503800
Total number of issued shares (5-year summary)CurrentQuarterInstant_NonConsolidatedMember56387000
Total number of issued shares (5-year summary)Prior1YearInstant_NonConsolidatedMember52640200
Net assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember1144629000JPY
Net assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1070531000JPY
Net assets (5-year summary)Prior1YearInstant_NonConsolidatedMember1157723000JPY
Total assets (5-year summary)Prior1QuarterInstant_NonConsolidatedMember1685551000JPY
Total assets (5-year summary)CurrentQuarterInstant_NonConsolidatedMember1557439000JPY
Total assets (5-year summary)Prior1YearInstant_NonConsolidatedMember1751454000JPY
Basic earnings loss per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember-13.70
Basic earnings loss per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember-10.21
Basic earnings loss per share (5-year summary)Prior1YearDuration_NonConsolidatedMember-24.62
Diluted earnings per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember-
Diluted earnings per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember-
Diluted earnings per share (5-year summary)Prior1YearDuration_NonConsolidatedMember-
Dividend paid per share (5-year summary)Prior1YTDDuration_NonConsolidatedMember-
Dividend paid per share (5-year summary)CurrentYTDDuration_NonConsolidatedMember-
Dividend paid per share (5-year summary)Prior1YearDuration_NonConsolidatedMember-
Equity to asset ratio (5-year summary)Prior1QuarterInstant_NonConsolidatedMember0.672
Equity to asset ratio (5-year summary)CurrentQuarterInstant_NonConsolidatedMember0.680
Equity to asset ratio (5-year summary)Prior1YearInstant_NonConsolidatedMember0.651
Net cash provided by used in operating activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember-595281000JPY
Net cash provided by used in operating activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember-677388000JPY
Net cash provided by used in operating activities (5-year summary)Prior1YearDuration_NonConsolidatedMember-1069192000JPY
Net cash provided by used in investing activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember82000JPY
Net cash provided by used in investing activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember-JPY
Net cash provided by used in investing activities (5-year summary)Prior1YearDuration_NonConsolidatedMember173000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YTDDuration_NonConsolidatedMember113359000JPY
Net cash provided by used in financing activities (5-year summary)CurrentYTDDuration_NonConsolidatedMember455490000JPY
Net cash provided by used in financing activities (5-year summary)Prior1YearDuration_NonConsolidatedMember667303000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-06-30pass